John Monahan

John James Monahan was the founder of Avigen, Inc., founded in 1992, where the title held was Chief Executive Officer from 1992 to 2004.
Dr. Monahan was the founder of Tacere Therapeutics, Inc., founded in 2006, where the title held was Director from 2006 to 2012.
Current jobs include Director at Elusys Therapeutics, Inc., Independent Director at Theriva Biologics, Inc. since 2020, Director at Cellix Ltd., Director at Spark Therapeutics Ireland Ltd., and Director at Luxcel Biosciences Ltd. Former jobs include Lead Independent Director at Anixa Biosciences, Inc. from 2016 to 2021, Director at GK Technologies, Inc., Director at IdentiGEN Ltd., Director-Molecular & Cell Biology at Triton Biosciences, Inc. from 1985 to 1989, Director at Trino Therapeutics Ltd. from 1985 to 1989, Independent Director at Scorpius Holdings, Inc. from 2009 to 2026, Vice President-Research & Development at Somatix Therapy Corp.
from 1989 to 1992, Group Head-Molecular Genetics at Hoffmann-La Roche, Inc. from 1982 to 1985, and Senior Executive VP-Research & Development at Theriva Biologics, Inc. from 2010 to 2015.
Education includes a doctorate from McMaster University conferred in 1974 and an undergraduate degree from University College Dublin conferred in 1969.